Elevance Health Inc. (ELV) Misses Q2 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ELV Hot Sheet
Join SI Premium – FREE
Elevance Health Inc. (NYSE: ELV) reported Q2 EPS of $8.84, $0.23 worse than the analyst estimate of $9.07. Revenue for the quarter came in at $49.4 billion versus the consensus estimate of $48.14 billion.
GUIDANCE:
Elevance Health Inc. sees FY2025 EPS of $30.00, versus the consensus of $34.48.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Flutter Entertainment (FLUT) PT Lowered to $160 at Jefferies
- Twilio (TWLO) PT Raised to $320 at Tigress Financial Partners
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
